B ACKGROUND: Acute myocardial infarction (AMI) is one of cardiovascular diseases with high morbidity and mortality rates. Novel biomarkers that can detect accurately acute coronary syndrome (ACS) at early stage, are necessary to improve current strategies and/or to identify subjects who are at risk. Fibrinogen and high-sensitivity C-reactive protein (hs-CRP) roles in inlammation process could be potential for ACS early detection. This study was conducted to evaluate measurements of ibrinogen and hs-CRP on ACS.
Introduction
Acute myocardial infarction (AMI) is one of cardiovascular diseases (CVDs) with high morbidity and mortality rates.
American Heart Association estimated that more than 6 millions Americans have coronary heart disease (CHD) and it is estimated that 1 million have myocardial infarction attack every year. CHD is also the leading cause of death (20%) in United States of America. Indonesian Domestic can be more potential biomarkers for ACS early detection, compared to other current biomarkers. This study evaluated measurements of ibrinogen and hs-CRP on ACS. (6, 15, 16) 
Study Design and Subjects Recruitment
This study was an analytic observational with cross sectional approach to evaluate the diagnostic value of ibrinogen and hs-CRP in establishing ACS diagnosis among patients hospitalized in Dr. Saiful Anwar Hospital with Troponin I positive. Subjects were men and women aged 35 to 80 years old with ACS as the case group and without ACS as the control group. Subjects with severe infection, liver function disorder, renal function disorder, and malignancy were eliminated from this study. This research was carried out on patients from emergency department and cardiovascular intensive care unit of Dr. Saiful Anwar Hospital.
Data Collection, Sample Preparation and Enzymelinked Immunosorbent Assay (ELISA)
After signing informed consent, proper anamnesis was conducted. Then blood sample was collected for complete blood count. Besides that, liver function, renal function, and blood glucose tests were all conducted. Samples of selected subjects were quantiied with enzyme-linked immunosorbent assay (ELISA) for Troponin I (Troponin I ELISA Kit, Sigma Aldrich, St. Louis, MO, USA), ibrinogen (Fibrinogen Human ELISA Kit, Abcam, Cambridge, UK) and hs-CRP (Quantikine® ELISA Human C-Reactive Protein/CRP Immunoassay, Minneapolis, MN, USA).
Statistical Analysis
Data was descriptively analyzed to portray the characteristics of case and control groups, as well as the information of classic risk factors and clinical characteristics. Differences of ibrinogen and hs-CRP in both groups were statistically examined with independent t-test. Correlation test was performed as well. To ind out which biomarker level has the highest accuracy to ACS, cut-off point for each level and logistic regression were carried out to ind the predicted probability value for ibrinogen combination data and hs-CRP as the basis of cut-off value determination through receiver operating curve (ROC). The sensitivity, speciicity, likelihood ratio and predictive value were further counted by using ibrinogen and hs-CRP, either separated or combination of both.
Methods
Health Survey / Survei Kesehatan Rumah Tangga (SKRT) performed in 1992, showed that people over 40 years old have CVD-caused mortality at the irst rank (16%).
Similar survey held in Java and Bali in 1995 pointed that CVD-caused mortality was at the irst rank as well, and its percentage (25%) was higher compared to the data from SKRT in 1992. Among CVD, CHD had the highest morbidity rate (30-36.1%). (1) High AMI morbidity and mortality rates suggested the necessity of an earlier diagnosis for immediate treatment and death prevention. Acute coronary syndrome (ACS) is a heart emergency situation of which clinical manifestation is chest discomfort or any other symptoms due to myocardial infarction. ACS consists of unstable angina pectoris. AMI is divided into ST segment elevation myocardial infarction (STEMI) and non STEMI (NSTEMI). (2, 3) To date, ACS diagnosis was determined by cardiac enzyme Troponin I or T measurements that could be detected started from 4 to 8 hours after the onset of chest pain. Troponin reached its peak level at 12-36 hours after the onset, then kept increasing for 7-9 days. False positive was commonly found in patients with chronic kidney disease (CKD) and those who were undergoing dialysis. Another biomarker for ACS is creatine kinase muscle brain that could be detected 4-6 hours after AMI onset and reaches its peak level within 18-24 hours then back to its normal value in 2-3 days. This biomarker is not quite speciic for cardiac muscle and false positive was sometimes found in patients with renal failure. (4, 5) Fibrinogen and C-reactive protein (CRP) are biomarkers that act as acute phase proteins. Fibrinogen plays role in coagulation process, blood viscosity, and platelet aggregation, while high sensitivity CRP (hs-CRP) works in inlammation process. Many studies have reported ibrinogen and hs-CRP used as an early stage detecting biomarker and prognosis decision for CHD.(6,7) If these two biomarkers were detected earlier in ACS patients, the proper treatment can be immediately given, and more extensive myocardial muscle damage can be prevented. (8, 9) Currently, in Indonesian hospitals, particularly in Dr. Saiful Anwar Hospital in Malang, the ibrinogen and hs-CRP measurements have not yet been considered as a routine procedure for ACS patients. Enzyme evaluation that is usually performed tends to relect that there has been cardiac muscle damages.(2,10,11) Meanwhile, the role of inlammatory marker in ACS diagnosis has been reported. (12) (13) (14) Fibrinogen and hs-CRP roles in inlammation process indicate that ibrinogen and hs-CRP There were 76 subjects in each group, hence there were totally 152 subjects of men and women. The mean of age was 57.5 years old. Comparison of ibrinogen and hs-CRP levels between ACS and non-ACS groups is shown in Table  1 . ACS group had higher levels of both ibrinogen and hs-CRP compared to Non-ACS group. Independent t-tests for ibrinogen and hs-CRP levels between ACS and non-ACS group were signiicant (p=0.000, p<0.05).
Results
Meanwhile, systolic and diastolic BP did not have signiicant differences between ACS and Non-ACS groups (p>0.05).
Cut-off for hs-CRP was set at 3.05 mg/L, while cut-off for ibrinogen was 4.25 g/L. More subjects with higher hs-CRP level (hs-CRP≥3.05 mg/L) were found in ACS group (69.7%) ( Table 4 ). More subjects with higher ibrinogen level (Fibrinogen ≥ 4.25g/L) were found in ACS group as well (72.4%). When hs-CRP cut-off was combined with ibrinogen cut-off, more subjects with higher hs-CRP and ibrinogen levels were found in ACS group (80.3%).
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Discussion
Characteristics of classic risk factor in ACS and non-ACS groups are shown in Table 2 . The evaluated risk factors were cigarette smoking, diabetes mellitus (DM), history of hypertension and ACS family history. DM was signiicantly higher in the ACS group than in non-ACS group. Hypertension was also found signiicantly higher in ACS group. Meanwhile, cigarette smoking behavior and ACS family history were also higher in ACS group, however the values were not signiicant (p>0.05).
Clinical characteristics in ACS and Non-ACS groups are shown in Table 3 . The evaluated clinical factors were systolic blood pressure (BP), diastolic BP, blood glucose and age. Not all clinical characteristics had signiicant differences between those two groups. The signiicant differences were found in blood glucose and age (p<0.05).
In combination, ibrinogen and hs-CRP showed the highest sensitivity (75.00%) ( Figure 5 ). The same results were also found in speciicity (80.26%), accuracy (77.63%), positive predictive value (PPV) (79.17%), and negative predictive value (NPV) (76.25%).
Our current results shows that detection of both ibrinogen and hs-CRP could provide high sensitivity, speciicity, accuracy, PPV and NPV results for ACS detection. Since ibrinogen and hs-CRP are related with ACS pathophysiology in early stage, these biomarkers could be useful for early detection of ACS. (17) (18) (19) Troponin I detection has higher sensitivity and speciicity than ibrinogen and hs-CRP. However, when Troponin I is detected, it will be ACS late stage, the cardiac muscle has undergone necrosis or irreversible death. Meanwhile ibrinogen and hs-CRP could be detected earlier, therefore, it could support early ACS treatment. (9, 17) Elevated inlammatory markers relect acute phase
response. An epidemiologic study has shown that levels of several inlammatory markers elevated few years prior to ACS manifestation. (9, 17) Increased levels of ibrinogen and hs-CRP in ACS without myocardial infarction correlated to the extent and severity of atherosclerosis, while CRP level in AMI correlated to the extent of tissue damage.
Various researches stated that inlammation is an integral
Non ACS (Mean ± SD) part of ACS. CRP is detected in damaged blood vessel or myocardium, and involves in inlammation process and thrombosis through complement activity. CRP is also directly related to tissue factor expression over monocyte surface. (3, 20) Fibrinogen and CRP levels are correlated to several classic risk factors like obesity, cigarette smoking, blood pressure and blood glucose. Healthy people, whose parents have AMI or ACS, can have higher CRP level compared to those without AMI family history. Higher ibrinogen and hs-CRP levels are reported more in subjects with multiple classic risk factors than in those with single classic risk factor. (20, 21) angina pectoris, it has been proven that ibrinogen and CRP can be the predictor of future AMI incidence and heart disease-caused death. (9) Response-to-injury hypothesis states that atherosclerosis is an inlammation disease. It is marked by the presence of inlammation process, endothelial cells and smooth muscle cells, release of cytokine and growth factor, complement activation and deposition, as well as elevated plasma protein level which is called acute phase reactant. (4,5) Inlammation process that involves macrophage, lymphocyte, proteinase, and cytokine activations, promotes the thrombosis plaque rupture. (6, 9) The inlammatory cells are responsible for plaque destabilization by changing anti-adhesive and anti-coagulant into pro-coagulant resulting tissue factor in monocyte to cause plaque rupture. Therefore, evident of leukocytosis and elevated CRP level indicate AMI. In 15% of AMI patients, CRP elevation is reported although Troponin T remains negative. Haidari, et al. investigated the correlation between serum CRP and CHD with angiography in 450 individuals. The result shows that serum CRP was higher in individual with CHD than in control group (2.14 mg/L vs. 1.45 mg/L) and the correlation indicated that there was inlammatory process in CHD. (9) Previous studies demonstrate that ibrinogen could Our results show that combination of both markers, hs-CRP and ibrinogen provided higher speciicity and sensitivity. The ibrinogen and hs-CRP are factors those synergistically correlated to ACS pathophysiology. The hs-CRP inluences through inlammation phase, causing endothelial dysfunction and unstable plaques. (21) In sequence, ibrinogen takes part to the pathophysiology of ACS after plaque ruptured from coronary blood vessel by inducing coagulation cascade activation with the formation of ibrin ibers as the inal process. In which if the ibers bond to platelet, thrombus would eventually formed, thus promoting ACS. (5, 9, 17) Since ibrinogen and hs-CRP measurements could
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